Multiple sclerosis: Infectious hypothesis

Neurological Sciences

Volumn 22, Issue 2, 2001, Pages 179-185

  Granieri, E ^a   Casetta, I ^a   Tola, M R ^b   Ferrante, P ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Epidemiology; Infections; Multiple sclerosis; Risk factors

Indexed keywords

ADULT; AGE; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; FEMALE; GEOGRAPHY; HUMAN; IMMUNOLOGY; MALE; MULTIPLE SCLEROSIS; REVIEW; RISK FACTOR; STATISTICS; VIROLOGY;

ADULT; AGE FACTORS; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CHILD; FEMALE; GEOGRAPHY; HUMANS; MALE; MULTIPLE SCLEROSIS; RISK FACTORS;

EID: 0035317874     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720170021     Document Type: Article

References (48)

1. Rosati G (1990) Epidemiologia délia sclerosi multipla. In: Rosati G, Granieri E (eds) Manuale di neuroepidemiologia clinica. La Nuova Italia Scientifica, Rome, pp 143-182
2. Granieri E, Casetta I, Tola MR et al (1993) Multiple sclerosis: Does epidemiology contribute to providing etiological clues? JNeurolSci 115[Suppl]: 16-23
3. Sadovnik AD, Ebers G (1993) Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sei 20:17-29
4. Granieri E (1997) The epidemiologic study of exogenous factors in the etiology of multiple sclerosis. Introduction. Neurology 49[Suppl 2]:S2-S3
5. Compston DAS (1998) Distribution of multiple sclerosis. In: Compston DAS, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H (eds) McAlpine multiple sclerosis, 3rd edn. Churchill Livingstone, London Edinburgh New York Philadelphia Sydney Toronto, pp 63-100
6. Compston DAS ( 1998) Genetic susceptibility to multiple sclerosis. In: Compston DAS, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H (eds) McAlpine multiple sclerosis, 3rd edn. Churchill Livingstone, London Edinburgh New York Philadelphia Sydney Toronto, pp 101-142
7. Kurtzke JE (1993) Epidemiologic evidence of multiple sclerosis as an infection. Clin Microbiol Rev 6:382-427
8. Ebers GC, Sadovnick AD (1998) Epidemiology. In: Paty DW, Ebers GC (eds) Multiple sclerosis. FA Davis, Philadelphia, pp 5-28
9. Marie P ( 1884) Sclérose en plaques et maladie infecteuses. ProgMed 12:287-289
10. Ferrante P, Guerini FR (1999) Virus e sclerosi multipla. In: Canal N, Ghezzi A, Zaffaroni M, Zibetti A (eds) Sclerosi multipla attualità e prospettive. Masson, Milan, pp 248-268
11. Lassmann H, Wekerle H ( 1998) Experimental models of multiple sclerosis. In: Compston DAS, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H (eds) McAlpine multiple sclerosis, 3rd edn. Churchill Livingstone, London Edinburgh New York Philadelphia Sydney Toronto, pp 409-433
12. Lauer K (1995) Environmental associations with the risk of multiple sclerosis: the contribution of ecological studies. Acta Neurol Scand Suppl 161:77-88
13. Poskanzer DC, Shapira K, Miller H (1963) Multiple sclerosis and poliomyelitis. Lancet 2:917-921
14. Granieri E, Casetta I (1997) Common childhood and adolescent infections and multiple sclerosis. Neurology 49[Suppl 2]:S42-S54
15. Ruse T (1997) Cluster studies in multiple sclerosis. Neurology 49[Suppl 2]:S27-S32
16. Cook SD, Rohowsky-Kochan C, Bansil S, Dowling PC (1995) Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand Suppl 161:34-42
17. Granieri E, Casetta I, Tola MR et al ( 1997) Multiple sclerosis: interplay between racial-genetic and environmental factors. An overview. In: Rossi A, Annunziata P (eds) Jubilee collection. Tipografia Senese, Siena, pp 349-392
18. Granieri E, Casetta I, Tola MR, Rosati G (1999) Epidemiologia della sclerosi multipla. In: Canal N, Ghezzi A, Zaffaroni M, Zibetti A (eds) Sclerosi multipla attualità e prospettive. Masson, Milan, pp 2-38
19. Rosati G, Aiello I, Pirastru MI et al (1996) Epidemiology of multiple sclerosis in northwestern Sardinia: further evidence for higher frequency in Sardinians compared to other Italians. Neuroepidemiology 15:10-19
20. Granieri E, Casetta I, Govoni V et al (2000) The increasing incidence and prevalence of multiple sclerosis in a Sardinian province. Neurology 55:842-847
21. Kurtzke JF ( 1995) MS epidemiology world wide. One view of current status. Acta Neurol Scand Suppl 161:23-33
22. Poser CM, Benedikz J, Hibberd P (1992) The epidemiology of multiple sclersosis. The Iceland model. J Neurol Sei 111:143-152
23. Poser CM, Hibberd PL, Benedikz J (1988) Analysis of the "epidemic" of multiple sclerosis in the Faroe Islands. II Biostatistical aspects. Neuroepidemiology 7:181-189
24. Poser CM (1994) The epidemiology of multiple sclerosis: A general overview. Ann Neurol 36 [Suppl 2]:S180-S193
25. Ruse T, Gronning M, Klauber MR et al (1991) Clustering of residence of multiple sclerosis patients at age 13 to 20 years in Hordaland, Norway. Am J Epidemiol 133:932-938
26. Casetta I, Granieri E (2000) Clinical infections and multiple sclerosis: contribution from analytical epidemiology. J Neurovirol 6[Suppl 2]:S147-S151
27. Dalgleish AG (1997) Viruses and multiple sclerosis. Acta Neurol Scand Suppl 169:8-15
28. Monteyne P, Bureau JF, Brahic M (1998) Viruses and multiple sclerosis. Curr Opin Neurol 4:287-291
29. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komuria-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, Mandrand B and The Collaborative Research Group on Multiple Sclerosis (1997) Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sei USA94(l4):7583-7588
30. Munch M, Hvas J, ChristensenTet al (1997) The implications of Epslein-Barr virus in multiple sclerosis - a review. Acta Neurol Scand Suppl 169:59-64
31. Munch M, Riisom K, Christensen T et al (1998) The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients. Acta Neurol Scand 97:171-174
32. Martyn CN, Cruddas M, Compston DAS (1993) Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry 56:167-168
33. Lindberg C, Andersen O, Vahiné A et al (1991) Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis. Neuroepidemiology 1991:62-65
34. Haahr S, Koch-Henriksen N, Moller-Earsen LS, Andersen HM (1995) Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study. MultScler 1:73-77
35. Sibley WA, Bamford CR, Clark K (1985) Clinical viral infections and multiple sclerosis. Lancet i: 1313-1351
36. Andersen O, Lygner PE, Bergstrom T et al (1993) Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 240:417-422
37. Rapp NS. Gilroy J, Lerner AM ( 1995) Role of bacterial infection in exacerbation of multiple sclerosis. Am J Phys Med Rehabil 74:415-418
38. Metz LM, McGuinness SD, Harris C ( 1998) Urinary tract infections may trigger relapse in multiple sclerosis. Axone 19:67-70
39. Edwards S, Zvartau M, Clarks H et al (1998) Clinical relaps-es and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry 64:736-741
40. Marrie RA, Wolfson C, Sturkenboom MC et al (2000) Multiple sclerosis and antecedent infections: a case-control study. Neurology 54:2307-2310
41. Wandinger KP, Jabs W, Siekhaus A et al (2000) Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 55:178-184
42. Martin JR ( 1981 ) Herpes simplex virus type 1 and 2 and multiple sclerosis. Lancet 2:777-781
43. Bray PF, Luka J (1992) Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 42:1798-1804
44. Sanders VJ, Felisan S, Waddel A, Tourtellotte WW (1996) Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol 2:249-258
45. Soldan SS, Berti R, Salem N et al (1997) Association of human herpesvirus type 6 with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nature Med 3(12): 1394-1397
46. Rotola A, Caselli E, Cassai E et al (2000) Novel human herpesviruses and multiple sclerosis. J Neurovirol 6[Suppl 2]:S88-S9I
47. Ferrante P, Mancuso R, Pagani E et al (2000) Molecular evidence for a role of HSV-1 in multiple sclerosis acute attack. J Neurovirol 6[Suppl 2]:S109-S114
48. Hunter SF, Hafler DA (2000) Ubiquitous pathogens. Link between infection and autoimmunity in MS? Neurology 55:164-165